Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression.
Miyagi
M
M
Division of Nephrology and Urology, Ohta General Hospital, 29-5 Hachiman-cho, Ohta City, Gunma, 373-8585 Japan.
Muramatsu
M
M
Ishikawa
Y
Y
Ishii
T
T
Sakai
K
K
Arai
K
K
Aikawa
A
A
Ohara
T
T
Mizuiri
M
M
Hirayama
N
N
Hasegawa
A
A
D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D016212:Transforming Growth Factor beta / Q000378:metabolism*
D007166:Immunosuppressive Agents; D016212:Transforming Growth Factor beta; D016572:Cyclosporine; D016559:Tacrolimus